Hepatitis B and C: The Importance of Early Diagnosis, Screening, and Treatment to Prevent Cancer

Public health authorities and medical specialists are intensifying public awareness campaigns regarding viral hepatitis, emphasizing that chronic infections can progress to severe liver damage and cancer if left untreated. Across health institutions and municipal programs, medical professionals stress that early screening and timely medical intervention remain the most effective tools to curb long-term complications associated with Hepatitis B and Hepatitis C.

While acute infections can sometimes resolve on their own, chronic forms often persist silently for years without producing noticeable symptoms, giving the condition ample opportunity to cause progressive scarring, cirrhosis, and hepatocellular carcinoma.

Understanding the Risks of Untreated Viral Hepatitis

Medical professionals stress that routine blood tests—specifically surface antigen tests for Hepatitis B and antibody tests followed by RNA confirmatory tests for Hepatitis C—can detect infections long before irreversible damage occurs.

Public Health Outreach and Screening Initiatives

To combat low awareness rates, healthcare providers and local municipalities have ramped up educational campaigns and mobile testing stands. For instance, recent public health outreach events—such as informational stands set up at regional facilities like Tekirdağ City Hospital in observance of World Hepatitis Day—aim to educate the public on transmission routes, prevention, and the importance of early diagnosis (Hürriyet). Similar targeted educational programs have been rolled out for municipal sanitation workers and high-risk occupational groups to ensure vulnerable populations receive necessary guidance and vaccination options (İhlas Haber Ajansı).

Early diagnosis allows physicians to initiate antiviral therapies that suppress viral replication, dramatically reducing the likelihood of cirrhosis and liver cancer.

Modern Treatment Advances and Prevention Strategies

The therapeutic landscape for viral hepatitis has transformed remarkably over the past decade.

Prevention remains equally critical. Catching viral hepatitis in its earliest stages changes the trajectory of the disease, shifting the medical outcome from a potential cancer diagnosis to a successfully managed or cured condition.